Arch Therapeutics, Inc.
ARTH · OTC
9/30/2023 | 9/30/2022 | 9/30/2021 | 9/30/2020 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $223 | $747 | $2,267 | $959 |
| Short-Term Investments | $0 | $0 | $0 | $0 |
| Receivables | $0 | -$436 | -$307 | -$177 |
| Inventory | $1,365 | $1,415 | $1,094 | $968 |
| Other Curr. Assets | $363 | $873 | $615 | $392 |
| Total Curr. Assets | $1,950 | $2,598 | $3,668 | $2,143 |
| Property Plant & Equip (Net) | $5 | $2 | $5 | $5 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $4 | $4 | $4 | $4 |
| Total NC Assets | $8 | $6 | $9 | $8 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $1,958 | $2,604 | $3,676 | $2,151 |
| Liabilities | – | – | – | – |
| Payables | $2,304 | $1,328 | $408 | $342 |
| Short-Term Debt | $5,628 | $550 | $0 | $37 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | -$681 | $0 |
| Other Curr. Liab. | $1,534 | $1,442 | $1,319 | $267 |
| Total Curr. Liab. | $9,466 | $3,320 | $1,728 | $646 |
| LT Debt | $0 | $2,812 | $1,600 | $689 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $664 | $1,375 | $2,316 |
| Total NC Liab. | $0 | $3,476 | $2,975 | $3,005 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $9,466 | $6,797 | $4,702 | $3,652 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $5 | $250 | $237 | $193 |
| Retained Earnings | -$62,056 | -$55,073 | -$49,797 | -$43,556 |
| AOCI | -$0 | $0 | $0 | $0 |
| Other Equity | $54,543 | $50,630 | $48,535 | $41,863 |
| Total Equity | -$7,508 | -$4,193 | -$1,026 | -$1,500 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $1,958 | $2,604 | $3,676 | $2,151 |
| Net Debt | $5,405 | $2,615 | -$667 | -$233 |